使用定量药理学开发多发性硬化症治疗蛋白的案例-聚乙二醇干扰素β -1a, Daclizumab β， Natalizumab

{"title":"使用定量药理学开发多发性硬化症治疗蛋白的案例-聚乙二醇干扰素β -1a, Daclizumab β， Natalizumab","authors":"Xiao Hu, Yaming Hang, Lei Diao, K. Muralidharan, I. Nestorov","doi":"10.1002/9781119289234.CH18","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":162868,"journal":{"name":"Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases","volume":"69 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Case Examples of Using Quantitative Pharmacology in Developing Therapeutic Proteins in Multiple Sclerosis - Peginterferon Beta-1a, Daclizumab Beta, Natalizumab\",\"authors\":\"Xiao Hu, Yaming Hang, Lei Diao, K. Muralidharan, I. Nestorov\",\"doi\":\"10.1002/9781119289234.CH18\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":162868,\"journal\":{\"name\":\"Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases\",\"volume\":\"69 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/9781119289234.CH18\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/9781119289234.CH18","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}